N

nbx-wellness

browser_icon
Company Domain www.nbxwellness.com link_icon
lightning_bolt Market Research

NBX Wellness - Comprehensive Analysis Report



Summary


NBX Wellness, formerly known as Neurobiologix, was established in 2008 by Dr. Kendal Stewart and Kara Stewart-Mullens. The company focuses on customizing supplement regimens based on individual DNA, leveraging wellness professionals to create tailored supplement plans. NBX Wellness aims to provide wellness solutions through physician-designed, pharmaceutical-grade supplements and nutrigenomic testing with the mission of reducing the cost of nutritional regimens by formulating supplements with only necessary ingredients and cofactors.

1. Strategic Focus & Objectives


Core Objectives


  • Provide customized supplement recommendations based on individual DNA through nutrigenomic testing.

  • Offer clinically formulated, physician-designed supplements grounded in industry research.

  • Operate as a comprehensive wellness solutions provider extending beyond a traditional supplement company.

  • Support wellness providers by offering tools such as e-stores, educational content, and a platform to view patient information.

  • Reduce the cost of nutritional regimens by offering formulas with essential ingredients, thereby avoiding the necessity of purchasing multiple single-ingredient supplements.


Specialization Areas


  • Personalized supplementation based on individual DNA.

  • Physician-designed and clinically formulated supplements.

  • Comprehensive wellness solutions that go beyond simple supplements.

  • Support and tools for wellness providers.

  • Cost reduction in nutritional regimens via targeted formulations.


Target Markets


  • Individuals seeking personalized health solutions based on their genetic makeup.

  • Wellness providers looking for tools to support their practice and patients.


2. Financial Overview


Funding History


  • Total funds raised: $8.75 million.

  • Funding rounds: One seed round, two early-stage rounds, and one post-IPO round.

  • Series A round: $7.11 million (January 2021).

  • Key investors: MD Holdings and WSC & Company.


3. Product Pipeline


Key Products/Services


  • Categories: Products for brain and nervous system support, children's health, detoxification, gut health, immune support, methylation, and more.

  • Featured Products: DNA Sustain, Glutathione Topical, and Daily Cell Recharge.

  • Testing Services: Nutrigenomics Genetic Test Kits.

  • New Products: Berberine Complex, D3 5000 + K1&K2, Longevity Multi, and OmegaCell 1600 TG.


4. Technology & Innovation


Technology Stack


  • Nutrigenomics platform to analyze genetic variations influencing metabolism, detoxification, and nutrient absorption.

  • Proprietary Technologies:

  • Physician-designed recommendation engine using algorithms for personalized supplementation.

  • Custom, secure reporting platform for personalized genetic results.

  • Development of specialized, professional-grade nutritional formulas.

  • Scientific Methodologies:

  • Nutrigenomic testing analyzing over 100 genetic markers in 9 foundational wellness areas.

  • Genetic biomarkers connected to prevalent health concerns.


5. Leadership & Management


Executive Team


  • Kendal Stewart, MD: Chief Medical Advisor and heads the Product Advisory Board. Neurotologist and Neuroimmune Specialist.

  • Kara Stewart-Mullens: Chief Communication Officer. She partnered with her brother to launch their shared wellness vision.


6. Competitive Analysis


Information not available from the source provided.

7. Market Analysis


Information not available from the source provided.

8. Strategic Partnerships


  • Partner: Bionic Bloom.

  • Nature: Advanced nutrigenomics testing.

  • Benefits: Patients receive tailored plans for detoxification, supplementation, and peptide therapy based on their genetic profiles.


9. Operational Insights


  • Supplements designed by and for healthcare professionals.

  • Supplement plans focus on individual patient needs based on genetic guidance.

  • Pharmaceutical-grade ingredients sourced from validated raw material suppliers.

  • Products manufactured in the U.S. to current Good Manufacturing Practices (cGMP).


10. Future Outlook


Strategic Roadmap


  • Expand nutrigenomics testing and personalized peptide therapies.

  • Support providers in discerning factors contributing to imbalance.

  • Equip providers with tools to address cellular system dysfunction.

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI